We are live on ! Find out more
AI

Atom Investors Portfolio holdings

AUM $1.4B
1-Year Est. Return 23.77%
This Fund
S&P 500
This Quarter Est. Return
-14%
1 Year Est. Return
+23.77%
3 Year Est. Return
+63.44%
5 Year Est. Return
+52.26%
10 Year Est. Return
–
AUM
$229M
AUM Growth
+$14.9M
Cap. Flow
+$46.2M
Cap. Flow %
20.2%
Top 10 Hldgs %
30.87%
Holding
340
New
154
Increased
49
Reduced
36
Closed
93

Top Buys

Rank Stock Value
1
ADTN icon
Adtran
ADTN
+$3.78M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.4M
3
XRT icon
State Street SPDR S&P Retail ETF
XRT
+$3.34M
4
INVH icon
Invitation Homes
INVH
+$3.09M
5
TYL icon
Tyler Technologies
TYL
+$2.8M

Top Sells

Rank Stock Value
1
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$8M
2
IBB icon
iShares Biotechnology ETF
IBB
+$4.46M
3
SUMO
Sumo Logic, Inc. Common Stock
SUMO
+$4.07M
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.95M
5
EIG icon
Employers Holdings
EIG
+$2.88M

Sector Composition

Rank Sector Weight
1 Technology 13.61%
2 Financials 11.71%
3 Healthcare 11.02%
4 Industrials 7.36%
5 Real Estate 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDF icon
226
Cardiff Oncology
CRDF
$66.5M
$74K 0.03%
33,798
– –
PNT
227
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$74K 0.03%
10,793
-49,310
-82% -$377K
CHRS icon
228
Coherus Oncology
CHRS
$217M
$73K 0.03%
10,085
-20,417
-67% -$178K
HIPO icon
229
Hippo Holdings
HIPO
$830M
$70K 0.03%
+3,169
New +$117K
FLL icon
230
Full House Resorts
FLL
$80.1M
$69K 0.03%
+11,428
New +$88.1K
TEAD
231
Teads Holding Co
TEAD
$68.7M
$69K 0.03%
+13,790
New +$104K
ARHS icon
232
Arhaus
ARHS
$1.05B
$66K 0.03%
14,697
-70,316
-83% -$460K
LIDR icon
233
AEye
LIDR
$52.8M
$54K 0.02%
+950
New +$128K
TLRY icon
234
Tilray
TLRY
$618M
$51K 0.02%
+1,642
New +$77.6K
RIOT icon
235
Riot Platforms
RIOT
$7.63B
$43K 0.02%
+10,370
New +$96.3K
LONA
236
LeonaBio Inc
LONA
$66.3M
$37K 0.02%
+1,202
New +$110K
LOCL icon
237
Local Bounti
LOCL
$22.8M
$35K 0.02%
+844
New +$62.2K
JNCE
238
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$35K 0.02%
11,388
-60,544
-84% -$294K
ELOX
239
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$35K 0.02%
3,228
+399
+14% +$5.51K
ALGS icon
240
Aligos Therapeutics
ALGS
$26.2M
$27K 0.01%
+907
New +$30.8K
NMTR
241
DELISTED
9 Meters Biopharma
NMTR
$27K 0.01%
+5,117
New +$48.2K
LNAI
242
Lunai Bioworks
LNAI
$8.8M
$26K 0.01%
+166
New +$75.9K
AVYA
243
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$26K 0.01%
+11,807
New +$84.3K
GLHAW
244
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$25K 0.01%
+231,624
New +$55K
PRQR icon
245
ProQR Therapeutics
PRQR
$243M
$24K 0.01%
30,422
– –
ALBT
246
DELISTED
Avalon GloboCare
ALBT
$6K ﹤0.01%
+87
New +$7.26K
ABG icon
247
Asbury Automotive
ABG
$4.31B
– –
-1,620
Closed -$260K
ABNB icon
248
Airbnb
ABNB
$89.9B
– –
-3,172
Closed -$545K
ABR icon
249
Arbor Realty Trust
ABR
$964M
– –
-41,255
Closed -$704K
AEO icon
250
American Eagle Outfitters
AEO
$2.88B
– –
-49,260
Closed -$828K
8 9
10
11 12

Similar funds

SP
Steelhead Partners Seattle, Washington $1.39B AUM 0.01% 1-Year Est. Return
ELC
Edgar Lomax Company Kingstowne, Virginia $1.4B AUM 20.67% 1-Year Est. Return
HRES
Heitman Real Estate Securities Chicago, Illinois $1.39B AUM 6.59% 1-Year Est. Return
SRAIM
Scheer Rowlett & Associates Investment Management Toronto, Ontario, Canada $1.39B AUM 49.24% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.39B AUM 18.33% 1-Year Est. Return
TCC
Trans-Canada Capital Montreal, Quebec, Canada $1.39B AUM 16.61% 1-Year Est. Return
FCP
Fidelis Capital Partners Tampa, Florida $1.4B AUM 31.16% 1-Year Est. Return
SC
Sagefield Capital Dallas, Texas $1.39B AUM 60.14% 1-Year Est. Return

Atom Investors's Q2 2022 Portfolio in Review

As of Q2 2022, Atom Investors held 340 positions worth $229M, up 7% from $214M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Atom Investors deployed $46.2M of net new capital in Q2 2022, opening 154 new positions and adding to 49 existing holdings. Its largest new stake was Adtran: 208,646 shares worth $3.66M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 6.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P Regional Banking ETF, an estimated $8M trimmed.

  • Atom Investors's largest Q2 2022 buy was Adtran: 208,646 shares worth $3.66M.
  • Atom Investors added most to State Street SPDR S&P Biotech ETF in Q2 2022, an estimated $3.4M increase.
  • Atom Investors's biggest Q2 2022 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $8M.
  • Atom Investors fully exited Sumo Logic, Inc. Common Stock in Q2 2022, selling an estimated $4.07M.
  • Atom Investors's ten largest holdings make up 31% of its $229M portfolio in Q2 2022.
  • Atom Investors opened 154 new positions and closed 93 in Q2 2022.
  • Atom Investors's portfolio value rose 7% quarter-over-quarter to $229M.

Based on Atom Investors's 13F filing for Q2 2022, filed 15 Aug 2022.